The economic disaster still continues for the Australian companies. As per the recent report, the CSL has been let down by 8 percent of its entire profit this year as compared to the previous year's record.

For this reason, the company has now decided to invest 900 million dollars more for its shares for the backup. The fall down of the profit is due to the local currency's weak value. The CSL is the second lead in the world for making human plasma products.

The total revenue for the company in this year till June last has been recorded 1.05 billion dollars where in the same time it was 1.15 billion in the previous year.

As per the report, the Company had been also gross a profit of 1.16 to 1.26 billion dollars in exchange values in 2009 where now it is 950 million to 1.05 billion dollars.

As per the report, it may be expected 1.08 billion dollars as an average but it has gone down to 1.05 billion dollars which is undoubtedly a discontent for a company like CSL. The net revenue of the company is reported to be 4.63 billion dollars against 5.04 billion in its preceding year.